Cargando…

Running interference on miR-33: a new amplification loop for type I interferon in the host antiviral response

Detalles Bibliográficos
Autores principales:	Zhao, Fei, Fessler, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608119/ https://www.ncbi.nlm.nih.gov/pubmed/32055004 http://dx.doi.org/10.1038/s41423-020-0373-3

Ejemplares similares

Interferon gamma runs interference on persistent COVID-19
por: Elliott, Eric Isaac, et al.
Publicado: (2021)

Host-targeting oral antiviral drugs to prevent pandemics
por: Dwek, Raymond A, et al.
Publicado: (2022)

Host miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by upregulating type I interferons
por: Li, Liwei, et al.
Publicado: (2015)

Running interference
por: Powledge, Tabitha M.
Publicado: (2001)

miR-222 isoforms are differentially regulated by type-I interferon
por: Nejad, Charlotte, et al.
Publicado: (2018)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism
por: Ouimet, Mireille, et al.
Publicado: (2016)

Interferon‐mediated repression of miR‐324‐5p potentiates necroptosis to facilitate antiviral defense
por: Dou, Xiaoyan, et al.
Publicado: (2022)

An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities
por: Qian, Guanghui, et al.
Publicado: (2021)

Interferon Induced IFIT Family Genes in Host Antiviral Defense
por: Zhou, Xiang, et al.
Publicado: (2013)

Optimization of loop-mediated isothermal amplification-based method for detection of macrolide–lincosamide–streptogramin B resistance in Staphylococcus aureus
por: Deshamukhya, Chandrayee, et al.
Publicado: (2023)

SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2
por: Mu, Jingfang, et al.
Publicado: (2020)

Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19
por: Nasser, Nourhane, et al.
Publicado: (2021)

The Role of Optineurin in Antiviral Type I Interferon Production
por: Outlioua, Ahmed, et al.
Publicado: (2018)

LncRNAs in the Type I Interferon Antiviral Response
por: Suarez, Beatriz, et al.
Publicado: (2020)

Glial interference: impact of type I interferon in neurodegenerative diseases
por: Roy, Ethan, et al.
Publicado: (2022)

Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia
por: Crotta, Stefania, et al.
Publicado: (2013)

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

Antiviral effects of oleandrin
por: Newman, R., et al.
Publicado: (2021)

MiR-33 connects cholesterol to the cell cycle
por: Inukai, Sachi, et al.
Publicado: (2012)

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
por: Jiang, He-wei, et al.
Publicado: (2020)

Treatment of SARS with human interferons
por: Cinatl, J, et al.
Publicado: (2003)

Interference in scientific research on COVID-19 in Turkey
por: Bayram, Hasan, et al.
Publicado: (2020)

Fludarabine inhibits type I interferon-induced expression of the SARS-CoV-2 receptor angiotensin-converting enzyme 2
por: Xiu, Huiqing, et al.
Publicado: (2021)

Overexpressed miR-539 exacerbates Pseudomonas aeruginosa puenmonia by promoting inflammatory responses
por: Li, Jianbo, et al.
Publicado: (2023)

Clinical applicability of miR517a detection in liquid biopsies of ETMR patients
por: Madlener, Sibylle, et al.
Publicado: (2023)

Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense
por: Bogunovic, Dusan
Publicado: (2016)

I19 Antiviral actions of the interferon-inducible IFIT proteins
por: Sen, G.
Publicado: (2012)

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
por: Stegelmeier, Ashley A., et al.
Publicado: (2021)

IRGM1 supports host defense against intracellular bacteria through suppression of type I interferon in mice
por: Rai, Prashant, et al.
Publicado: (2023)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Antiviral activities of interferons
por: Stewart, William E., et al.
Publicado: (1979)

Quit Smoking and Run For Your Life!
por: Mathew, BC, et al.
Publicado: (2008)

Does the linear Sry transcript function as a ceRNA for miR-138? The sense of antisense
por: Granados-Riveron, Javier Tadeo, et al.
Publicado: (2014)

Critical analysis of the hypothesized SNHG1/miR-195-5p/YAP1 axis
por: Zielske, Steven P., et al.
Publicado: (2022)

Rationale of receptor-based antivirals against SARS
Publicado: (2013)

Early triple antiviral therapy for COVID-19
por: Lee, Nelson, et al.
Publicado: (2020)

Putative antiviral effects of propofol in COVID-19
por: Wei, Penghui, et al.
Publicado: (2021)

Inhibition of the Type I Interferon Antiviral Response During Arenavirus Infection
por: Borrow, Persephone, et al.
Publicado: (2010)

Species-independent bioassay for sensitive quantification of antiviral type I interferons
por: Kuri, Thomas, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vsht3rdtmpmbmobor9um82rvvc